Sharp 2015 Annual Report Download - page 31

Consolidated Balance Sheets
Sharp Corporation and Consolidated Subsidiaries as of March 31, 2014 and 2015
Yen
(millions)
2014 2015
ASSETS
Current Assets:
Cash and cash equivalents (Note 7) ¥ 350,634 ¥ 232,211
Time deposits (Note 7) 20,768 22,439
Restricted cash (Note 7) 8,194 3,843
Notes and accounts receivable (Note 7) —
Trade 423,552 405,583
Other 130,538 181,196
Nonconsolidated subsidiaries and affiliates 20,612 22,946
Allowance for doubtful receivables (5,850) (4,054)
Inventories (Note 3) 295,126 338,300
Deferred tax assets (Note 4) 23,733 16,576
Other current assets 106,937 80,155
Total current assets 1,374,244 1,299,195
Property, Plant and Equipment, at Cost (Note 6):
Land 92,784 87,619
Buildings and structures 718,606 658,741
Machinery, equipment, vehicles and others 1,719,244 1,651,778
Construction in progress 21,415 19,896
2,552,049 2,418,034
Less accumulated depreciation (2,032,348) (2,017,442)
519,701 400,592
Investments and Other Assets:
Investments in securities (Notes 2 and 7) 61,593 58,556
Investments in nonconsolidated subsidiaries and affiliates (Note 7) 112,418 109,239
Other assets (Note 4) 113,724 94,327
287,735 262,122
¥ 2,181,680 ¥ 1,961,909
Yen
(millions)
2014 2015
LIABILITIES AND NET ASSETS
Current Liabilities:
Short-term borrowings, including current portion of long-term debt
(Notes 5 and 7) ¥ 793,198 ¥ 848,947
Notes and accounts payable (Note 7) —
Trade 347,175 390,621
Construction and other 35,892 42,672
Nonconsolidated subsidiaries and affiliates 26,846 34,726
Accrued expenses 235,203 229,712
Income taxes (Note 4) 22,056 15,251
Valuation reserve for inventory purchase commitments — 54,655
Other current liabilities (Note 4) 91,255 70,370
Total current liabilities 1,551,625 1,686,954
Long-term Liabilities:
Long-term debt (Notes 5 and 7) 300,321 125,329
Net defined benefit liability (Note 12) 101,383 85,277
Deferred tax liabilities (Note 4) 10,904 7,727
Other long-term liabilities 10,274 12,107
Total long-term liabilities 422,882 230,440
Contingent Liabilities (Note 11)
Net Assets (Note 9):
Shareholders’ equity
Common stock:
Authorized — 2,500,000 thousand shares
Issued — 1,701,214 thousand shares in 2014 and 2015 121,885 121,885
Capital surplus 95,950 95,945
Retained earnings (accumulated deficits) 135,096 (87,448)
Less cost of treasury stock:
10,449 thousand shares in 2014 and
10,480 thousand shares in 2015 (13,889) (13,893)
339,042 116,489
Accumulated other comprehensive income
Net unrealized holding gains (losses) on securities 6,851 10,569
Deferred gains (losses) on hedges (160) 780
Foreign currency translation adjustments (41,206) (18,106)
Remeasurements of defined benefit plans (109,367) (79,566)
(143,882) (86,323)
Minority interests 12,013 14,349
Total net assets 207,173 44,515
¥ 2,181,680 ¥ 1,961,909
The accompanying notes to the consolidated financial statements are an integral part of these statements.
29
Consolidated Balance Sheets
Financial Section
Segment Outline
Medium-Term Management Plan
for Fiscal 2015 through 2017
Investor Information
Directors, Audit & Supervisory Board
Members and Executive Officers
Risk Factors
Corporate Governance
Contents
Corporate Social
Responsibility (CSR)
Message to our Shareholders
Fiscal 2014 Review by
Product Group
Financial Highlights
SHARP Annual Report 2015
Consolidated
Subsidiaries
Independent Auditor’s
Report
Notes to the Consolidated
Financial Statements
Consolidated Statements of
Cash Flows
Consolidated Statements of
Changes in Net Assets
Consolidated Statements of
Comprehensive Income
Consolidated Statements of
Operations
Financial Review
Five-Year Financial Summary